Introduction
Sleep is a normal physiological process that is of great importance to us all [1] . Santos et al. [2] demonstrate that there are few studies on chronic obstructive pulmonary disease (COPD) establishing the differences between the functional parameters of the disease and sleep variables.
Aim
The aim of the work was to study sleep pattern changes in COPD patients.
Patients and methods
The study was conducted at the Chest Department in Sayed Galal, Al Azhar University on 45 individuals during the period from October 2016 to December 2017, who were divided into two groups: the first is the study group which included 30 patients with mild to moderate COPD according to GOLD's 2017 classification [based on post-bronchodilator forced expiratory volume 1 (FEV 1 )] in patients with FEV 1 / forced vital capacity (FVC) of less than 0.70 and who were classified into GOLD 1: mild when an FEV 1 of at least 80% was predicted, GOLD 2: moderate (50%) when an FEV 1 of less than 80% predicted, GOLD 3: severe (30%) when an FEV 1 of less than 50% was predicted, GOLD 4: very severe when an FEV 1 of less than 30% was predicted [3] . The second group is the control group, it included 15 healthy volunteer individuals.
All individuals (diseased group 1 and control group 2) were admitted in the Chest Department and all underwent the following: history taking and examination were done, BMI calculations, plain chest radiography posteroanterior view, ECG, arterial blood gas analysis, pulmonary function test, and complete overnight polysomnography that was conducted in the Sleep Unit of the Chest Department, Al Azhar University. They should abstain from caffeine in the afternoon and the evening of the day of the study, and should avoid alcohol, and strenuous exercise. They were also advised to avoid naps on the day of the study. All patients continue their usual medications on the night of the study, recorded by the technician to help in interpretation. Individuals are connected to monitoring devices during the study which include EEGmonitoring electrodes, EMG electrodes, sensors for respiratory effort, transducers for thoracoabdominal movement, snoring monitors, and oximetry sensors.
The technologist periodically documents the relevant information as the study proceeds. This usually includes the heart rate, respiratory rate, oxygen saturation, presence or absence of snoring and its volume, and body positions. Respiratory analysis like apnea, hypopnea, and apnea/hypopnea index was performed.
Apnea was defined as a cessation or near cessation of airflow; it is characterized as being obstructive, central, or mixed. Hypopnea was defined as an abnormal reduction of airflow to a degree that is insufficient to meet the criteria for an apnea [4] .
Physiologic variables are recorded digitally on a computerized system (Neuron-Spectrum device; Neurosoft Company; Ivanovo, Russia). The system provides computer assistance by tabulating and collating the scored data. All individuals were asked to sign a written informed consent that proves their acceptance of joining the study.
Results
In the present study, there were 14 women and 16 men COPD patients and there were six women and nine men in the control group; so, there is insignificant difference among the studied patients regarding sex distribution (P=0.671) ( Table 1 ).
In the present study, the mean age of the COPD patients was 55.50±10.54 and in the control group was 47.73±7.52; so, there is significant difference between COPD patients and the controlled group regarding age (P=0.013) ( Table 2 ).
In the present study, the mean BMI in COPD patients was 39.28±8.54 and in the control group was 26.70± 3.64; so, there is significant difference between COPD patients and the control group regarding BMI (P<0.001) ( Table 2 ).
In the present study, the mean apnea numbers in COPD patients was 17.27±26.82 and in the control group was 3.07±1.83; so, there is no statistically significance between COPD patients and the control group regarding apnea numbers (P=0.537) ( Table 3 ). The mean hypopnea numbers in COPD patients was 55.70±76.46 and in the control group was 5.20±2.86; so, there is significant difference between COPD patients and the control group regarding hypopnea numbers (P=0.019) ( Table 3 ). The mean apnea/hypopnea index in COPD patients was 16.02 ±17.04 and in the control group it was 1.22±0.54; so, there is significant difference between COPD patients and the control group regarding apnea/hypopnea index (P<0.001) ( Table 3 ). The mean of sleep efficiency in COPD patients was 70.29±21.59 and in the control group was 84.97±7.08; so, there is no significant difference between COPD patients and the control group regarding sleep efficiency (P=0.079) (Table 3) ; the mean of snoring index in COPD patients was 171.20±221.97 and in the control group it was 10.35±4.32. Therefore, there is significant difference between COPD patients and the control group regarding snoring index (P=0.009) ( Table 3 ).
In the present study, the mean sleep efficiency in mild COPD patients was 77.25±16.83; in moderate COPD patients was 67.76±22.90 and in the control group it was 84.97±7.08. So, there is no significant difference between mild, moderate COPD patients, and the control group regarding sleep efficiency (P=0.141) ( Table 3 ). The mean apnea numbers in mild COPD patients was 3.62±4.03; in moderate COPD patients it was 22.23±29.85; and in the controlled group it was 3.07±1.83; so, there is no significant difference between mild, moderate COPD patients, and the controlled group regarding apnea numbers (P=0.412) ( Table 3 ). The mean hypopnea numbers in mild COPD patients was 8.50±10.56; in moderate COPD patients it was 72.86±82.94; and the mean hypopnea numbers in the controlled group was 5.20±2.86. So, there is significant difference between mild, moderate COPD patients and the control group regarding hypopnea numbers (P=0.005) ( Table 3 ). The mean apnea/hypopnea index in mild COPD patients was 3.30±3.34; in moderate COPD patients it was 20.64 ±17.70; and in the control group it was 1.22±0.54; so, there is significant difference between mild, moderate COPD patients, and the control group regarding apnea/ hypopnea index (P<0.001) ( Table 3 ). The mean snore index in mild COPD patients was 40.90±63.79; in moderate COPD patients was 218.58±240.55; and in the controlled group was 10.35±4.32. So, there is significant difference between mild, moderate COPD patients, and the control group regarding snore index (P=0.001) (Table 3) .
In this study, the mean of maximum heart rate in COPD patients was 109.80±13.08 and in the controlled group was 93.33±5.27 so, there is significant difference between COPD patients and the controlled group regarding maximum heart rate (P<0.001) (Table 4) , the mean of average heart rate in COPD patients was 82.50±10.28 and in the controlled group was 71.40±3.94 so, there is significant difference between COPD patients and the controlled group regarding average heart rate (P<0.001) ( (Table 4 ).
In the present study, the mean sleeping SO 2 in COPD patients was 91.70±3.75% and in the control group it was 96.53±1.19%; so, there is significant difference between COPD patients and the control group regarding sleeping SO 2 (P<0.001) ( Table 5 ). The mean of minimum sleeping SO 2 in COPD patients was 78.07±9.10 and in the control group it was 93.80± 1.93; so, there is significant difference between COPD patients and the control group regarding minimum sleeping SO 2 (P<0.001) ( Table 5 ).
In the present study, the mean sleeping SO 2 in mild COPD patients was 94.50±1.07; the mean sleeping SO 2 in moderate COPD patients was 90.68±3.87; and the mean sleeping SO 2 in the control group was 96.53± 1.19; so, there is significant difference between mild, moderate COPD patients, and the control group (P<0.001) ( Table 5 ). The mean of minimum sleeping SO 2 in mild COPD patients was 85.38±5.93; the mean of minimum sleeping SO 2 in moderate COPD patients was 75.41±8.65; and the mean of minimum sleeping SO 2 in the control group was 93.80±1.93; so, there is significant difference between mild, moderate COP patients, and the control group regarding minimum sleeping SO 2 (P<0.001) ( Table 5 ).
In the present study, the mean PH in COPD patients was 7.40±0.05 and in the control group it was 7.40± 0.04; so, there is no significant difference between COPD patients and the control group regarding pH (P=0.638) ( Table 6 ). The mean PaCO 2 in COPD patients was 44.09±11.87 and in the control group it was 38±2.56; so, there is no significant difference between COPD patients and the control group regarding PaCO 2 (P=0.135) ( Table 6 ). The mean PaO 2 in COPD patients was 70.18±12.81 and in the control group was 91.13±2.07; so, there is significant difference between COPD patients and the control group regarding PaO 2 (P<0.001) ( Table 6 ). The mean HCO 3 in COPD patients was 27.15±5.37 and in the control group it was 25.90±1.65; so, there is no significant difference between COPD patients and the control group regarding HCO 3 (P=0.745) ( Table 6 ). The mean SO 2 in COPD patients was 90.50±6.10 and in the control group it was 97.00±0.93; so, there is significant difference between COPD patients and the control group regarding SO 2 (P<0.001) ( Table 6 ).
In the present study, the mean value of pH in mild COPD patients was 7.42±0.06; the mean value of pH in moderate COPD patients was 7.39±0.05; and the mean value of pH in the control group was 7.40±0.04; so, there is no significant difference between mild, moderate COPD patients, and the control group regarding pH value (P=0.500) ( The mean of SO 2 in mild COPD patients was 91.27±6.02; the mean of SO 2 in moderate COPD patients was 88.39±6.21; and the mean of SO 2 in the control group was 97.00±0.93; so, there is significant difference between mild, moderate COPD patients, and the control group regarding SO 2 (P<0.001) ( Table 6 ).
In the present study, the mean predicted %FVC value in COPD patients was 109.60±28.82% and in the control group was 93.25±8.93%; so, there is no significant difference between COPD patients and the control group regarding the predicted %FVC value (P=0.155) ( Table 7 ). The mean predicted % FEV 1 value in COPD patients was 73.08±12.08% and in the control group was 98.87±12.17%; so, there is significant difference between COPD patients and the control group regarding predicted % FEV 1 value (P<0.001) ( Table 7 ). The mean FEV 1 / FVC ratio in COPD patients was 55.99±10.19 and in the control group it was 88.19±5.54; so, there is significant difference between COPD patients and the control group regarding FEV 1 /FVC ratio (P<0.001) ( Table 7 ).
In the present study, the mean predicted %FVC value in mild COPD patients was 130.62±22.22%; in moderate COPD patients it was 101.95±27.44%; and in the control group it was 93.25±8.93; so, there is significant difference between mild, moderate COPD patients, and the control group regarding predicted %FVC value (P=0.008) ( Table 7) . The mean predicted %FEV 1 value in mild COPD patients was 88.38±7.27%; in moderate COPD patients it was 67.51±7.90%; and in the control group it was 98.87±12.17%; so, there is significant difference between mild, moderate, and the control group regarding predicted %FEV 1 value (P<0.001) ( Table 7 ). The mean FEV 1 /FVC ratio in mild COPD patients was 56.03±7.63; in moderate COPD patients it was 55.98±11.14; and in the control group it was 88.19±5.54; so, there is significant difference between mild, moderate COPD patients, and the control group regarding FEV 1 /FVC ratio (P<0.001) ( Table 7) .
Discussion
In the present study, the predicted mean FVC% was 109.6±28.82% in patients with COPD which showed no statistically significance with that of the control group which was 93.25±8.93% (P=0.155) and the mean FEV 1 % predicted was 73.08±12.08% in COPD patients which is significantly lower than that of the control group which was 98.87±12.17% (P<0.001) and the mean FEV 1 /FVC ratio was 55.99± 10.19% in COPD patients which showed statistical significance with that of the control group which was 88.19±5.54% (P<0.001) ( Table 7) .
And these results are in agreement with the results found by Silva et al. [5] who demonstrate that the predicted mean FVC% was 104.6±0.3% in patients with COPD; the mean predicted FVC% was 92.7 ±15.7% in the control group; the mean predicted FEV 1 % was 88-67.5±7.7-7.4% in patients with COPD; the mean predicted FEV 1 % was 96.4±15.2% in the control group; the mean FEV 1 /FVC ratio was 66.9-64.4±12.5-3.3% in patients with COPD; and the mean FEV 1 /FVC ratio was 81.3±5.3% in the control group. There are also in agreement with the results found by Watson et al. [6] who found that the mean predicted FEV 1 value was 79.2% in patients with COPD and the mean FEV 1 /FVC ratio was 63.7±7.3% in patients with COPD, which are also in agreement with the values in study done by Goncalves et al. [7] who found that the mean predicted FVC% was 96.6±9.59% in the control group; the mean predicted FEV 1 % was 94±9.44% in the control group; and the mean FEV 1 /FVC ratio was 98.3±7.66% in the control group. These results are also in agreement with the values in the study done by Lin et al. [8] who found that the mean predicted FVC% was 98.7±19.4% in patients with COPD and the mean predicted FEV 1 % was 70.8±22.4% in patients with COPD, and are in agreement with the values in In the present study of patients with COPD the mean pH was 7.40±0.05 which showed no statistical significance with that of the control group which was 7.40±0.04 (P=0.638) ( Table 6 ).
The mean PaCO 2 in patients with COPD was 44.09± 11.87 which also showed no statistical significance with that of the control group which was 38.00±2.56 (P=0.135).
The mean PaO 2 value in COPD patients was 70.18± 12.81 which showed a statistical significance compared with the control group which was 91.13±2.07 (P<0.001).
The mean HCO 3 value in COPD patients was 27.15± 5.37 which showed no statistical significance with that of the control group which was 25.90±1.65 (P=0.745).
Our results of arterial blood gases in COPD patients agree with the values in the study done by El-Sorougi et al. [10] who found that the mean value of pH was 7.40±0.02; the mean value of PCO 2 was 44.90±2.77; the mean value of PaO 2 was 69.30±6.25; and the mean value of HCO 3 was 28.90±2.02.
Also these results are in agreement with the results of Ak et al. [11] who found that the mean value of pH was 7.40±0.08; the mean value of PCO 2 was 44.7± 12.4; the mean value of PaO 2 was 59.4±15.1; the mean value of HCO 3 was 27.2±4.7; and the mean value of SO 2 was 87.6±9.2, which were close to those found in Delclaux et al. [12] who found that the mean value of PaCO 2 was 40.5±6.1 and the mean value of PaO 2 was 75.2±10.8 and those of O'Connor et al. [13] who found that the mean value of pH was 7.39±0.04; the mean value of PaCO 2 was 49.7±14.25; the mean value of PaO 2 was 67.65±18.5; the mean value of HCO 3 was 29.66±6.28; and the mean value of SO 2 was 92.06±5.72.
Moreover, our results of arterial blood gases in the control group are in agreement with the values in the study done by El-Sorougi et al. [10] , who found that the mean value of pH was 7.42±0.02; the mean value of PaCO 2 was 40.27±2.61; the mean value of PaO 2 was 88.91±2.91; and the mean value of HCO 3 was 26.18±1.47.
In patients with COPD the mean sleeping SO 2 was 91.70±3.75%, and the mean of minimum sleeping SO 2 was 78.07±9.10%, in agreement with El-Sorougi et al. [10] , who revealed that the mean sleeping of SO 2 was 91.70±5.14%, and the mean of minimum sleeping SO 2 was 77.90±9.45%, also in agreement with the results obtained by Mulloy et al.
[21] who revealed that the mean sleeping SO 2 was 91±4.3%, and the mean of minimum sleeping SO 2 was 79±10.5%, which are also in agreement with the results obtained by Kajal et al. [16] who revealed the mean sleeping SO 2 was 93.18%, and the mean of minimum sleeping SO 2 was 80.27%, also in agreement with the results obtained by McSharry et al. [14] who revealed that the mean sleeping SO 2 was 89.6±4%, and the mean of minimum sleeping SO 2 was 81.2±7.5%, and i this study there is a statistical significance between the two groups in mean sleeping SO 2 and in minimum sleeping SO 2 with the P values being less than 0.001 and less than 0.001, respectively ( Table 5 ).
Conclusion
The present study concludes that there is a change in sleep pattern between mild to moderate COPD patients and normal individuals.
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